2408. Is Shorter Antibiotic Treatment Feasible in Patients with Cardiac Implantable Electronic Devices (CIED) Infections? Impact of Treatment Duration on 6-Month Recurrence and Mortality

Giacomo Ponta(San Raffaele University of Rome), Marco Ripa(Vita-Salute San Raffaele University), Alessandra Marzi(Vita-Salute San Raffaele University), Antonella Castagna(Vita-Salute San Raffaele University), Paolo Della Bella(Centro Cardiologico Monzino), Vincenzo Spagnuolo(IRCCS Ospedale San Raffaele), Paolo Scarpellini(Innovation Engineering (Italy)), Chiara Tassan Din(Vita-Salute San Raffaele University), Patrizio Mazzone(IRCCS Ospedale San Raffaele), Chiara Oltolini(Ospedale Maggiore), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Martina Ranzenigo(Vita-Salute San Raffaele University)
Open Forum Infectious Diseases
November 27, 2023
10.1093/ofid/ofad500.2028
Cited by 0

Related Papers

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
|European Heart Journal|2008|2.7k
Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|Circulation|2003|583
Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study
|Heart Rhythm|2015|497
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
|EP Europace|2019|461